A previous systematic review reported that APOE4 + AD patients showed relatively more tau in the medial temporal lobe, while APOE4 − AD patients had more tau in other cortical regions, such as the frontal and parietal lobes8. This evidence concerns the gene MAPT and Alzheimer disease.